Pink Sheet

In Brief: Seven drug import alerts, seven EU GMP findings, several particulates recalls

30 Apr 2014

Baxter, Sun, Apotex and four other firms received FDA import alerts in March and April, while another seven firms were found non-compliant with EU GMPs. Meanwhile, Hospira, Shire and Cubist recalled product due to particulates and FDA revised its inspection refusal import alert.

Due to failures to meet drug GMP requirements, FDA issued alerts blocking imports of drugs from seven firms in March and April: